Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Reply to Correspondence

Reply to correspondence on “Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis”

Abdelrahman M Attia, Hasmik Adetyan, Ju Dong Yang

Clin Mol Hepatol. 2024;30(4):1042-1043. Published online August 27, 2024

DOI: https://doi.org/10.3350/cmh.2024.0685

View: 607 Download: 26 Web of Science: 1 Crossref: 1

Correspondence

Correspondence to editorial on “Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients”

Xiaoqian Xu, Hong You, Jidong Jia, Yuanyuan Kong

Clin Mol Hepatol. 2024;30(4):994-996. Published online July 23, 2024

DOI: https://doi.org/10.3350/cmh.2024.0552

View: 791 Download: 26 Web of Science: 1 Crossref: 1

Original Article

KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression

Young Hoon Jung, Yun Ji Lee, Tam Dao, Kyung Hee Jung, Junjie Yu, Ah-Reum Oh, Yelin Jeong, HyunJoon Gi, Young Un Kim, Dongryeol Ryu, Michele Carrer, Utpal B. Pajvani, Sang Bae Lee, Soon-Sun Hong, KyeongJin Kim

Clin Mol Hepatol. 2024;30(4):895-913. Published online August 5, 2024

DOI: https://doi.org/10.3350/cmh.2024.0364

View: 1582 Download: 251

Editorial

Decreasing performance of HCC prediction models during antiviral therapy for hepatitis B: what else to keep in mind: Editorial on “Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients”

Beom Kyung Kim

Clin Mol Hepatol. 2024;30(4):656-658. Published online July 8, 2024

DOI: https://doi.org/10.3350/cmh.2024.0499

View: 778 Download: 29 Crossref: 2

Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis: Editorial on “Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging”

Abdelrahman M Attia, Hasmik Adetyan, Ju Dong Yang

Clin Mol Hepatol. 2024;30(4):653-655. Published online July 1, 2024

DOI: https://doi.org/10.3350/cmh.2024.0482

View: 1008 Download: 55

Review

Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication

Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming-Lung Yu

Clin Mol Hepatol. 2024;30(3):326-344. Published online April 26, 2024

DOI: https://doi.org/10.3350/cmh.2024.0155

View: 2713 Download: 152 Web of Science: 4 Crossref: 2

Editorial

The gene expression signature of metabolic dysfunction- associated steatotic liver disease from a multiomics perspective

Carlos Jose Pirola, Silvia Sookoian

Clin Mol Hepatol. 2024;30(2):174-176. Published online February 5, 2024

DOI: https://doi.org/10.3350/cmh.2024.0082

View: 2524 Download: 75 Web of Science: 1 Crossref: 1

The latest evidence on the impact of fatty liver on liver-related outcomes and mortality in chronic hepatitis B

Xianhua Mao, Lung Yi Mak, Wai-Kay Seto

Clin Mol Hepatol. 2023;29(3):690-692. Published online May 30, 2023

DOI: https://doi.org/10.3350/cmh.2023.0173

View: 2512 Download: 101 Web of Science: 1 Crossref: 1

Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed

Philipp Kasper, Münevver Demir, Hans-Michael Steffen

Clin Mol Hepatol. 2023;29(2):390-393. Published online March 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0059

View: 3173 Download: 65 Web of Science: 2 Crossref: 2

Challenges in translating clinical guidelines into real-life practice for management of hepatocellular carcinoma in Taiwan

San-Chi Chen

Clin Mol Hepatol. 2023;29(2):352-354. Published online March 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0101

View: 3247 Download: 66

Review

Detect or not to detect very early stage hepatocellular carcinoma? The western perspective

Ju Dong Yang

Clin Mol Hepatol. 2019;25(4):335-343. Published online March 29, 2019

DOI: https://doi.org/10.3350/cmh.2019.0010

View: 11612 Download: 251 Web of Science: 43 Crossref: 42

Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?

Chung-Feng Huang, Ming-Lung Yu

Clin Mol Hepatol. 2019;25(2):168-171. Published online February 11, 2019

DOI: https://doi.org/10.3350/cmh.2018.1014

View: 6363 Download: 186 Web of Science: 5 Crossref: 5

4

A Case of Complete Remission in Ruptured Hepatocellular Carcinoma after One - time Transcatheter Arterial Chemoembolization

Doo Yul Ryu,Duc Ky Lee,Jong Hyung Kim,Hyun Min Shin,Dong In Hwang,Dong Joo Lee,Sang Kook Han,Seok En Kim,Suk Joon Park

Clin Mol Hepatol. 1999;5(4):343-347. Published online January 1, 2000

View: 2374 Download: 13

3

Serum Concentration of Intercellular Adhesion Molecule-1 (ICAM-1) in Patients with Hepatocellular Carcinoma (HCC) with Low AFP

Hyun Ju Park, Joung Il Lee, Seok Ho Dong, Hyo Jong Kim, Byoung Ho Kim, Young Woon Chang and Rin Chang

Clin Mol Hepatol. 1998;4(4):346-357. Published online January 1, 2000

View: 2474 Download: 14

Correspondence

Correspondence on Editorial regarding “KCTD17 as a RAS stabilizer in hepatocellular carcinoma progression”

Sang Bae Lee, KyeongJin Kim

Received September 4, 2024 Accepted September 7, 2024

DOI: https://doi.org/10.3350/cmh.2024.0750 [Accepted]

View: 353 Download: 41

Review Article

Mechanisms of HCC and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B

Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto

Received September 25, 2024 Accepted November 16, 2024

DOI: https://doi.org/10.3350/cmh.2024.0837 [Accepted]

View: 315 Download: 43

1 |

Viewed By 5070	Examining the therapeutic landscape of beta-blockers in portal hypertension
Viewed By 5067	MAFLD: How is it different from NAFLD?
Viewed By 4484	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4450	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4356	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 248	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 198	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 145	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 138	MAFLD: How is it different from NAFLD?
Cited By 113	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search